| Name | desvaleroyl valsartan |
|---|---|
| Synonyms |
N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
(S)-2-(((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoic acid (S)-3-methyl-2-((2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl)amino)butyric acid (S)-3-methyl-2-((2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl)-amino)-butyric acid N-{[2'-(2H-Tetrazol-5-yl)-4-biphenylyl]methyl}-L-valine L-Valine, N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (S)-2-(((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)amino)-3-methylbutanoic acid Valsartan Impurity 11 |
| Description | Devaleryl Valsartan Impurity is an intermediate in the synthesis of Valsartan[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 598.2±60.0 °C at 760 mmHg |
| Molecular Formula | C19H21N5O2 |
| Molecular Weight | 351.402 |
| Flash Point | 315.6±32.9 °C |
| Exact Mass | 351.169525 |
| PSA | 103.79000 |
| LogP | 3.52 |
| Vapour Pressure | 0.0±1.8 mmHg at 25°C |
| Index of Refraction | 1.609 |
| Precursor 0 | |
|---|---|
| DownStream 1 | |